Back

CHA Biotech joins K-CGTAP quality platform project running through 2030

Verifying
  • CHA Biotech joined a project building K-CGTAP, a public quality assessment platform.
  • About 13.7 billion won will fund the project, including roughly 12.7 billion won from government sources.
  • CHA Bundang Medical Center leads the research, which runs from April 2026 through December 2030.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
CHA Biotech joins K-CGTAP quality platform project running through 2030 - CoinPost Terminal